Neoadjuvant inetetamab and pertuzumab with taxanes and carboplatin (TCbIP) In locally advanced HER2-positive breast cancer: a prospective cohort study with propensity-matched analysis
Article in BMC Cancer (July 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in BMC Cancer (July 2024)
Article in Journal of Pharmaceutical Analysis (January 2024)